These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8793557)

  • 1. A defect in beta-galactosidase of B lymphocytes in the osteopetrotic (op/op) mouse.
    Yamamoto N; Naraparaju VR
    Immunol Lett; 1996 Apr; 50(1-2):35-40. PubMed ID: 8793557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A defect in inducible beta-galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse.
    Yamamoto N; Naraparaju VR
    Immunology; 1996 Aug; 88(4):604-10. PubMed ID: 8881764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats.
    Yamamoto N; Lindsay DD; Naraparaju VR; Ireland RA; Popoff SN
    J Immunol; 1994 May; 152(10):5100-7. PubMed ID: 8176226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of vitamin D3-binding protein in activation of mouse macrophages.
    Yamamoto N; Naraparaju VR
    J Immunol; 1996 Aug; 157(4):1744-9. PubMed ID: 8759764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of beta-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages.
    Naraparaju VR; Yamamoto N
    Immunol Lett; 1994 Dec; 43(3):143-8. PubMed ID: 7721326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats.
    Yamamoto N; Naraparaju VR
    Cell Immunol; 1996 Jun; 170(2):161-7. PubMed ID: 8660814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective lymphocyte glycosidases in the macrophage activation cascade of juvenile osteopetrosis.
    Yamamoto N; Naraparaju VR; Orchard PJ
    Blood; 1996 Aug; 88(4):1473-8. PubMed ID: 8695868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.
    Yamamoto N; Homma S
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8539-43. PubMed ID: 1924312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The toothless osteopetrotic rat has a normal vitamin D-binding protein-macrophage activating factor (DBP-MAF) cascade and chondrodysplasia resistant to treatments with colony stimulating factor-1 (CSF-1) and/or DBP-MAF.
    Odgren PR; Popoff SN; Safadi FF; MacKay CA; Mason-Savas A; Seifert MF; Marks SC
    Bone; 1999 Aug; 25(2):175-81. PubMed ID: 10456382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells.
    Yamamoto N; Kumashiro R
    J Immunol; 1993 Sep; 151(5):2794-802. PubMed ID: 8360493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages.
    Yamamoto N; Homma S; Millman I
    J Immunol; 1991 Jul; 147(1):273-80. PubMed ID: 2051023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D-binding protein (group-specific component) is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine.
    Homma S; Yamamoto M; Yamamoto N
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():249-57. PubMed ID: 8225394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of peritoneal macrophages by lysophosphatidylcholine.
    Ngwenya BZ; Yamamoto N
    Biochim Biophys Acta; 1985 Mar; 839(1):9-15. PubMed ID: 3978122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structurally well-defined macrophage activating factor derived from vitamin D3-binding protein has a potent adjuvant activity for immunization.
    Yamamoto N; Naraparaju VR
    Immunol Cell Biol; 1998 Jun; 76(3):237-44. PubMed ID: 9682967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of defective and normal immunologic functions in lymphocytes and macrophages from osteopetrotic (op) rats.
    Hochman N; Wahl LM; Sandberg AL
    J Immunol; 1982 Jul; 129(1):278-81. PubMed ID: 7086133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of serum proteins in the inflammation-primed activation of macrophages.
    Yamamoto N; Willett NP; Lindsay DD
    Inflammation; 1994 Jun; 18(3):311-22. PubMed ID: 8088927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The macrophage system in the intestinal muscularis externa during inflammation: an immunohistochemical and quantitative study of osteopetrotic mice.
    Mikkelsen HB; Larsen JO; Hadberg H
    Histochem Cell Biol; 2008 Aug; 130(2):363-73. PubMed ID: 18392842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage colony-stimulating factor is indispensable for repopulation and differentiation of Kupffer cells but not for splenic red pulp macrophages in osteopetrotic (op/op) mice after macrophage depletion.
    Yamamoto T; Kaizu C; Kawasaki T; Hasegawa G; Umezu H; Ohashi R; Sakurada J; Jiang S; Shultz L; Naito M
    Cell Tissue Res; 2008 May; 332(2):245-56. PubMed ID: 18335245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients.
    Yamamoto N; Naraparaju VR; Asbell SO
    Cancer Res; 1996 Jun; 56(12):2827-31. PubMed ID: 8665521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of lysophosphatidylcholine-treated nonadherent cells to mechanism of macrophage activation.
    Ngwenya BZ; Yamamoto N
    Proc Soc Exp Biol Med; 1990 Feb; 193(2):118-24. PubMed ID: 2300592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.